- Home
- NVCT vs EDF Comparison
NVCT vs EDF Comparison
Compare NVCT & EDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVCT | EDF |
|---|---|---|
| Founded | 2020 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 171.9M | 154.9M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | NVCT | EDF |
|---|---|---|
| Price | $7.53 | $4.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $15.33 | N/A |
| AVG Volume (30 Days) | 91.2K | ★ 160.6K |
| Earning Date | 11-04-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.14% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.44 | $3.51 |
| 52 Week High | $11.52 | $5.50 |
Technical Indicators
Market Signals| Indicator | NVCT | EDF |
|---|---|---|
| Relative Strength Index (RSI) | 72.98 | 35.52 |
| Support Level | $6.47 | $4.88 |
| Resistance Level | $6.84 | $4.90 |
| Average True Range (ATR) | 0.39 | 0.05 |
| MACD | 0.16 | -0.00 |
| Stochastic Oscillator | 95.77 | 15.79 |
Price Performance
Historical ComparisonAbout NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About EDF Virtus Stone Harbor Emerging Markets Income Fund of Beneficial Interest
Virtus Stone Harbor Emerging Markets Income Fund is a closed-end management investment company. Its investment objective is to maximize total return, which consists of income from its investments and capital appreciation. The Fund normally will invest at least 80% of its net assets (plus any borrowings for investment purposes) in emerging markets securities.